FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns a pharmaceutical composition in the form of a capsule either acid-resistant, or with an acid-resistant coating containing recombinant interferon specified from alpha, beta, gamma recombinant interferon; a stabiliser of the biological, physical and chemical properties specified in low-molecular polyvinylpyrrolidone, macrogol 400-12000, propylene glycol, hydroxypropyl methylcellulose; a stabiliser of microbial contamination resistance specified in dexamethasone, diflorazone, boric acid, phospholipids, cyclodextrins, calcium stearate, and/or magnesium stearate, a thickly-forming base specified in hydrophilic, lipophilic, hydrophilic-lipophilic bases.
EFFECT: invention provides a higher therapeutic effect and prolonged shelf life.
3 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
| ANTIVIRAL AGENT | 2000 |
|
RU2187330C1 |
| DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
| CURATIVE AGENT | 2000 |
|
RU2187332C1 |
| MEDICINAL FOR VAGINAL APPLICATION, WITH ANTIVIRAL, ANTIMICROBIAL, ANTIFUNGAL, ANTIPROTOZOAL, ANTIINFECTIOUS, IMMUNOMODULATING AND ANTIINFLAMMATORY ACTION, AS OINTMENT, GEL, SUPPOSITORY | 2016 |
|
RU2633056C1 |
| CONDOM LUBRICANT | 2000 |
|
RU2187329C1 |
| TABLETTED PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE FORMS OF VIRAL INFECTIONS | 2014 |
|
RU2559179C1 |
| ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 2000 |
|
RU2187328C1 |
| MEDICINAL PREPARATION | 2000 |
|
RU2187331C1 |
| PHARMACEUTICAL COMPOSITION DENTOFERON IN FORM OF GEL FOR PREVENTING AND TREATING PERIODONTAL DISEASES | 2012 |
|
RU2490006C1 |
Authors
Dates
2013-05-27—Published
2012-04-02—Filed